Fig. 5.
Amino acid interactions between repurposed drug candidates and the protein targets of SARS-CoV-2 from our previous studies [105]. The targets shown are spike glycoprotein, nucleocapsid phosphoprotein, and NSP16 (middle row). The repurposed drugs that interacted with it included remdesivir, lopinavir, hydroxychloroquine, favipiravir, ritonavir, and chloroquine (top and bottom rows)